February 6, 2018 / 4:08 PM / 8 months ago

BRIEF-Ziopharm Oncology Addresses Rumors And Stock Volatility, Affirms 2018 Guidance

Feb 6 (Reuters) - Ziopharm Oncology Inc:

* ZIOPHARM ONCOLOGY ADDRESSES RUMORS AND STOCK VOLATILITY, AFFIRMS 2018 GUIDANCE

* COMPANY REAFFIRMS ITS GUIDANCE FOR ALL ACTIVITIES IN 2018

* ZIOPHARM HAS HAD NO DISCUSSIONS AND HAS NO PLANS TO UNDERTAKE AN UNDERWRITTEN STOCK OFFERING AT THIS TIME​

* AS OF DEC. 31, 2017, CO HAD $70.9 MILLION OF CASH RESOURCES & $34.6 MILLION FROM PRE-PAYMENT FOR PROGRAMS TO BE CONDUCTED BY CO

* CURRENT RESOURCES WILL BE SUFFICIENT TO FUND ITS CURRENTLY PLANNED OPERATIONS INTO Q4 OF 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below